The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
910561211 9105612 11 F 20110223 20160729 20130221 20160803 EXP US-GLAXOSMITHKLINE-A0919029A GLAXOSMITHKLINE 43.45 YR M Y 66.00000 KG 20160803 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
910561211 9105612 1 PS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 50 NG/KG/MIN54 NG/KG/MIN60 NG/KG/MIN, CONCENTRATION 75,000 NG/ML, PUMP RATE 82 ML/DAY, VIAL STR[...] U H578 20444 50 DF POWDER FOR INFUSION
910561211 9105612 2 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U C592216 20444 POWDER FOR INFUSION
910561211 9105612 3 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U N644 20444 POWDER FOR INFUSION
910561211 9105612 4 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U S706 20444 POWDER FOR INFUSION
910561211 9105612 5 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U S501 20444 POWDER FOR INFUSION
910561211 9105612 6 SS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) UNK, CO U T794 20444 POWDER FOR INFUSION
910561211 9105612 7 SS FLOLAN EPOPROSTENOL SODIUM 1 56 NG/KG/MIN, CO U V378 20444 POWDER FOR INFUSION
910561211 9105612 8 SS FLOLAN EPOPROSTENOL SODIUM 1 56 NG/KG/MIN, CO U V785 20444 56 DF POWDER FOR INFUSION
910561211 9105612 9 SS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 41 NG/KG/MIN (CONCENTRATION 45,000 NG/ML, PUMP RATE 93 ML/DAY, VIAL STRENGTH 1.5 MG), CO U Z606 0 SOLUTION FOR INJECTION
910561211 9105612 10 SS REMERON MIRTAZAPINE 1 45 MG, U U 0 45 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
910561211 9105612 1 Pulmonary arterial hypertension
910561211 9105612 9 Pulmonary arterial hypertension
910561211 9105612 10 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
910561211 9105612 OT
910561211 9105612 HO
910561211 9105612 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
910561211 9105612 Catheter site erythema
910561211 9105612 Catheter site infection
910561211 9105612 Cellulitis
910561211 9105612 Constipation
910561211 9105612 Cough
910561211 9105612 Dehydration
910561211 9105612 Dyspnoea
910561211 9105612 Headache
910561211 9105612 Hypotension
910561211 9105612 Incorrect dose administered
910561211 9105612 Infusion site infection
910561211 9105612 Nausea
910561211 9105612 Overdose
910561211 9105612 Pneumonia
910561211 9105612 Prescribed overdose
910561211 9105612 Vomiting
910561211 9105612 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
910561211 9105612 1 20020517 0
910561211 9105612 2 20020517 0
910561211 9105612 3 20020517 0
910561211 9105612 4 20020517 0
910561211 9105612 5 20020517 0
910561211 9105612 6 20020514 0
910561211 9105612 7 20020508 0
910561211 9105612 8 20020508 0
910561211 9105612 9 20020505 0